http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140136685-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21e107158476ddc12479f9b8c25ad465 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
| filingDate | 2013-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b315d7e9642b87df02490ff15e98c7fd |
| publicationDate | 2014-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20140136685-A |
| titleOfInvention | Pharmaceutical composition for suppression of dendritic cell maturation comprising ellagic acid as effective component |
| abstract | The present invention relates to a pharmaceutical composition for inhibiting dendritic cell maturation comprising eragacic acid as an active ingredient, and more particularly to a pharmaceutical composition for inhibiting dendritic cell maturation comprising eragic acid or a pharmaceutically acceptable salt thereof as an active ingredient, A pharmaceutical composition for preventing or treating autoimmune disease, and a health food for preventing or improving autoimmune disease. The ellagic acid of the present invention inhibits the ripening of dendritic cells induced by lipopolysaccharide, and thus is useful for the prevention and treatment of autoimmune diseases such as Lupus syndrome, Sjogren's syndrome, rheumatoid arthritis and type 1 diabetes It can be beneficial to consumers' health. |
| priorityDate | 2013-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.